# Intellia Therapeutics (NTLA) to Present New Clinical Data on Nexiguran at 2024 AHA Scientific Sessions

Ella Sullivan · October 9, 2024

> Intellia Therapeutics (NTLA) to Present New Clinical Data on Nexiguran at 2024 AHA Scientific Sessions....

### Related reading

- [7 Transformative Applications of AI in Scientific Image Analysis From Neural Networks to Visual Recognition in 2024](https://kahma.io/blog/7_transformative_applications_of_ai_in_scientific_image_anal.php)
- [Beyond the Buzz: Evaluating the Impact of 36 Mentoring Sessions on Startup Potential](https://kahma.io/blog/beyond_the_buzz_evaluating_the_impact_of_36_mentoring_sessi.php)
- [Optimizing EMR Templates 7 Strategies to Enhance Clinical Workflow Efficiency in 2024](https://kahma.io/blog/optimizing_emr_templates_7_strategies_to_enhance_clinical_wo.php)
- [Do AI Headshots Pass LinkedIn? Inside a 30-Day Live Test](https://kahma.io/blog/do-ai-headshots-pass-linkedin-inside-a-30-day-live-test.php)
- [512px SDXL Headshots Pass USCIS APIGR: Translation Over Upscaling](https://kahma.io/blog/512px-sdxl-headshots-pass-uscis-apigr-translation-over-upscaling.php)
- [Python Beats R for Biometric Checks on Vertex AI: Latency & Cost](https://kahma.io/blog/python-beats-r-for-biometric-checks-on-vertex-ai-latency-cost.php)

### Latest

- [Do AI Headshots Pass LinkedIn? Inside a 30-Day Live Test](https://kahma.io/blog/do-ai-headshots-pass-linkedin-inside-a-30-day-live-test.php)
- [512px SDXL Headshots Pass USCIS APIGR: Translation Over Upscaling](https://kahma.io/blog/512px-sdxl-headshots-pass-uscis-apigr-translation-over-upscaling.php)
- [Python Beats R for Biometric Checks on Vertex AI: Latency & Cost](https://kahma.io/blog/python-beats-r-for-biometric-checks-on-vertex-ai-latency-cost.php)
- [ResNet-50 Inference: Python vs Keras 3 for ID Verification](https://kahma.io/blog/resnet-50-inference-python-vs-keras-3-for-id-verification.php)

Canonical: https://kahma.io/blog/intellia_therapeutics_ntla_to_present_new_clinical_data_on.php
Markdown: https://kahma.io/blog/intellia_therapeutics_ntla_to_present_new_clinical_data_on.php/index.md